Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Sapient Capital LLC acquired a new stake in shares of McKesson Corporation (NYSE: MCK) during the th

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far t

The recommendations of Wall Street analysts are often relied on by investors when deciding whether t

In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move fr

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in f

Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and raise

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth ex

AMD, CEG, MRVL, OPCH, FCEL were among the stocks seen trending on Tuesday, Oct. 6, 2026.

Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice

Option Care Health agreed to a $5.8B buyout by CD&R and McKesson at $32.05 per share, pending sh

Private equity firm CD&R and McKesson Corporation (NYSE:MCK) on Tuesday agreed to acquire Option Car

CD&R and McKesson acquire Option Care Health in a $5.8 billion transaction at $32.05 per share a

Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubi

Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while Mc

What happened McKesson Corporation (NYSE: MCK) said on October 6, 2026, it signed a definitive agree

CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (NASDA

NEW YORK & IRVING, Texas & BANNOCKBURN, Ill.--(BUSINESS WIRE)--CD&R, McKesson Corporation (NYSE: MCK

McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 6.56% on an annualized bas

Park National Corp OH lowered its stake in shares of McKesson Corporation (NYSE: MCK) by 8.2% in the

The arrangement is now in force through June 2032. McKesson also reaffirmed its guidance for the cur

Bond yields hit their highest level in two decades, pressuring blue chip dividend stocks and weighin

Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaff

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential

McKesson Corporation (NYSE: MCK) announced today it is reaffirming its fiscal year 2027 adjusted EPS

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has signed

McKesson (MCK) reached $853.81 at the closing of the latest trading day, reflecting a -1.27% change

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 22.21% on an annualized bas

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.05% on an annualized bas

RBC Capital analyst Ryan Halsted reiterates McKesson (NYSE:MCK) with a Sector Perform and maintai

A September filing shows that Representative Jonathan Jackson reported a sale in Viasat (NASDAQ:VSAT

McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 3.54% on an annualized bas

McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research an

Barclays analyst Glen Santangelo maintains McKesson (NYSE:MCK) with a Overweight and raises the p

RBC Capital analyst Ryan Halsted initiates coverage on McKesson (NYSE:MCK) with a Sector Perform

Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and raises t

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.04% on an annualized bas

TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and raises the price targ

UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target f

Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and

McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 ana

McKesson (NYSE:MCK) reported quarterly earnings of $9.93 per share which beat the analyst consensus

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $

TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and lowers the price targ

July 8, 2026 records indicate that Representative Ritchie Torres filed a purchase of McKesson (NYSE: